Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$334K Sell
2,276
-63
-3% -$11.4K 0.17% 75
2026
Q1
$344K Buy
2,339
+769
+49% +$125K 0.21% 67
2025
Q4
$306K Buy
+1,570
New +$374K 0.18% 68
2025
Q2
Sell
-1,754
Closed -$247K 64
2025
Q1
$247K Buy
1,754
+118
+7% +$19.2K 0.22% 67
2024
Q4
$273K Buy
+1,636
New +$291K 0.25% 62

Other funds holding ORCL

SharpePoint's ORCL Position: Q2 2026 in Review

SharpePoint reduced its Oracle (ORCL) stake by 2.7% in Q2 2026, selling an estimated $11.4K and leaving 2,276 shares worth $334K. The position accounts for 0.17% of the portfolio, ranked #75.

SharpePoint first reported a position in ORCL in Q4 2024 and has held it in 5 quarters since. The position peaked at $344K in Q1 2026. 3,519 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • SharpePoint held 2,276 shares of Oracle worth $334K as of Q2 2026.
  • SharpePoint sold 63 Oracle shares in Q2 2026, an estimated $11.4K.
  • Oracle made up 0.17% of SharpePoint's portfolio in Q2 2026, its #75 holding.
  • SharpePoint first reported a position in Oracle in Q4 2024 and has held it in 5 quarters since.
  • SharpePoint's Oracle position peaked at $344K in Q1 2026.
  • 3,519 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on SharpePoint's 13F filing for Q2 2026, filed 29 Jul 2026.